ALGN — Align Technology Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $166.00
- YTD price return
- +6.31%
- YTD total return
- +6.31%
- Market cap
- 11.7B
- Enterprise value
- 10.7B
- Shares outstanding
- 70.5M
- 52W low
- $130.23
- 52W high
- $200.44
- From 52W high
- -17.18%
- From 52W low
- +27.47%
- 52W range
- 51%$130–$200
- Beta
- 1.64
Volume
- Rel volume
- 1.68×
- 30D volume
- 1M
- 30D $ vol
- 157.3M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$1.5M
Form 4 transactions by trade date, as filed; latest on file 2026-02-18.
Fundamentals
- Sales (ttm)
- 4.2B
- Sales/share
- $59.00
- EPS (ttm)
- $6.88
- FCF (ttm)
- 602.5M
- FCF/share
- $8.55
- Book value/share
- $61.08
- Net margin
- 11.83%
- ROE
- 11.42%
- ROA
- 7.54%
- Current ratio
- 1.42
Growth (CAGR, ttm) · 10Y
- Sales
- +4.42%+2.99%+2.06%+15.13%
- Net income
- +30.01%+10.67%-7.85%+9.93%
- FCF
- +6.33%-4.24%-8.43%+13.30%
- Shares
- -1.76%-2.73%-2.22%-1.22%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +33.33%+13.50%-5.82%+11.36%
- Sales/share
- +6.29%+5.88%+4.37%+16.55%
- FCF/share
- +8.24%-1.55%-6.36%+14.70%
- Book value/share
- +10.75%+7.16%+6.49%+17.48%
- Price
- +24.15%-5.67%-24.72%+6.83%
- Total return
- +24.15%-5.67%-24.72%+6.83%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 24.1×
- P/OI (ttm)
- 18.9×
- Fwd P/E
- 14.0×
- P/S (ttm)
- 2.8×
- P/B (mrq)
- 2.7×
- P/FCF (ttm)
- 19.4×
- EV/EBITDA (fy)
- 12.5×
- EV/Sales (ttm)
- 2.6×
- FCF yield (ttm)
- 5.15%
- Buyback yield (realized, 1y)
- 1.76%
- Shareholder yield (realized, 1y)
- 1.76%
- Buyback yield (cash, ttm)
- 2.38%
- Shareholder yield (cash, ttm)
- 2.38%
Vs own 10Y history
- P/E
- 11th
- P/OI
- 5th
- P/S
- 6th
- P/B
- 6th
- P/FCF
- 7th
Bar = where today’s multiple sits in ALGN’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +7.1%10Y CAGR +11.2%YoY +75.7%EPS (diluted)
5Y CAGR −24.1%10Y CAGR +12.3%YoY +143.6%Free cash flow
5Y CAGR −0.7%10Y CAGR +10.3%YoY −18.4%TTM: operating cash flow $749.9M, capex −$147.4M
Q3 2026: operating cash flow $182.9M, capex −$45M
Shares (diluted)
5Y −8.4%10Y −11.0%YoY −1.9%Net income
5Y CAGR −25.4%10Y CAGR +11.0%YoY +138.0%About Align Technology#
Data provided bySource: Twelve DataAlign Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.
Tempe, AZ·20,435 employees·Medical Instruments & Supplies·aligntech.com·As of Oct 28, 2026
Recent filings#
- Nov 68-K · ALIGN TECHNOLOGY ANNOUNCES $270 MILLION ACCELERATED STOCK REPURCHASE AGREEMENT
- Oct 28Earnings · Earnings release — EPS $2.37 vs $2.32 est. (+2.2%); revenue $1.01B (+2% y/y) 0.1%
- Oct 288-K · Align Technology Announces CEO Succession Plan
- Aug 318-K · QUENTIN BLACKFORD TO JOIN ALIGN TECHNOLOGY BOARD OF DIRECTORS
- Jul 29Earnings · Earnings release — EPS $2.05 vs $2.08 est. (−1.4%); revenue $1.06B (+4% y/y) 3.7%
ETFs holding ALGN#
28 of the 193 ETFs ChartRow carries live hold ALGN. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| VBR | Vanguard Small-Cap Value ETF | 0.2% |
| XLV | Health Care Select Sector SPDR Fund | 0.2% |
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VHT | Vanguard Health Care ETF | 0.2% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.0% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
